# Losartan + Sunitinib in Treatment of Osteosarcoma

> **NCT03900793** · PHASE1 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 41 (estimated)

## Conditions studied

- Osteosarcoma

## Interventions

- **DRUG:** Losartan
- **DRUG:** Sunitinib

## Key facts

- **NCT ID:** NCT03900793
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-08-26
- **Primary completion:** 2026-08
- **Final completion:** 2027-02
- **Target enrollment:** 41 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03900793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03900793, "Losartan + Sunitinib in Treatment of Osteosarcoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03900793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*